Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor
Hero Background

Medical Devices Market

ID: MRFR/MED/2123-CR
200 Pages
Satyendra Maurya, Rahul Gotadki
Last Updated: May 23, 2026
Medical Devices Market Research Report Information by Device Type (Drug Delivery Systems, Diagnostic Devices, Invasive Devices, Respiratory Therapeutic Devices, Electronic Medical Devices, and Others), By Application (Cardiovascular Diseases, Diagnostic Imaging, Orthopedics, Oncology, General Surgery, Respiratory, ENT, Neurology, Nephrology & Urology, and Others), By End User (Hospitals & Clinics, Ambulatory Surgical Centers, Homecare Settings, and Others) By Region (North America, Europe, Asia Pacific, South America, Middle East & Africa) - Forecast to 2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Medical Devices Market Summary

Global Medical Devices Market Size was valued at USD 641,899 Million in 2024 & the market is projected to grow from USD 688,180 Million in 2025 to USD 1,377,540 Million by 2035, registering a CAGR of 7.21% during the forecast period 2025–2035. North America led the market with over 40% share, generating around USD 256759.60 million in revenue.
 
Rising prevalence of chronic diseases and the expanding elderly population are major growth drivers for the medical devices market, increasing demand for diagnostic imaging, wearable monitoring systems, minimally invasive surgical technologies, and AI-enabled healthcare solutions that improve treatment precision, patient outcomes, and operational efficiency globally.
 
According to WHO Data Portal, noncommunicable diseases account for approximately 41 million deaths annually, representing nearly 74% of total global deaths. Additionally, the growing aging population and increasing healthcare utilization are significantly accelerating adoption of advanced diagnostic, monitoring, and therapeutic medical devices across hospitals and specialty care centers worldwide.

Key Market Trends & Highlights

The Medical Devices Market is a rapidly expanding sector driven by aging populations, chronic disease prevalence, and technological innovations like AI and minimally invasive tools.

  • North America holds over 40% share, supported by USD 45 billion NIH funding and 50 million surgeries annually.
  • Europe reached USD 192,569.70 million with 30% share, driven by over 25% elderly population and rising chronic diseases.
  • Diagnostic devices lead with 56% share, while therapeutic devices at 29% grow rapidly with personalized treatment adoption.
  • Hospitals dominate with 62% share, while home care at 21% expands due to remote monitoring demand.

Market Size & Forecast

2024 Market Size 6,41,899 (USD Million)
2035 Market Size 13,77,540 (USD Million)
CAGR (2025 - 2035) 7.21%

Major Players

Companies such as Johnson & Johnson, GE Healthcare, Stryker, Beckton Dickinson and Company, Boston Scientific Corporation, Abbott are some of the major participants in the global market.

Our Impact
Enabled $4.3B Revenue Impact for Fortune 500 and Leading Multinationals
Partnering with 2000+ Global Organizations Each Year
30K+ Citations by Top-Tier Firms in the Industry

Medical Devices Market Trends

The medical devices market is a rapidly growing sector within healthcare which is driven by technological innovation, demographic changes and increasing healthcare expenditure. Increasing prevalence of chronic diseases, an aging global population and increasing demand for minimally invasive procedures are fueling the adoption of advanced medical devices.

Technological advancements such as robotics, AI-assisted diagnostics, wearable devices and smart implants are continuously expanding the portfolios of the product where regulatory frameworks like FDA approvals and ISO standards ensure safety, quality and reliability. The market also benefits from expanding healthcare infrastructure which emerges in the economies and creates new growth opportunities. 

  • Johnson & Johnson continues strengthening medical technology innovation through robotic surgery, AI-assisted diagnostics, and minimally invasive solutions, supported by annual R&D investments exceeding USD 15 billion. The company’s strategic collaborations and expanding MedTech portfolio are accelerating adoption of connected healthcare devices, improving surgical precision, and supporting increasing global demand for advanced patient-centric treatment technologies.

However, the challenges such as high R&D costs, stringent regulatory requirements and intense competition persist. Overall, the medical devices market thrives on innovation. The world medical equipment market is undergoing robust growth due to the high rate of technological advancement, rising rates of chronic and lifestyle diseases, and the growing rates of healthcare spending in the developed and emerging markets.

Medical devices encompass the wide variety of products like drug delivery systems, diagnostic equipment, invasive and implantable devices, respiratory therapeutic equipment, and electronic medical equipment intended to help patients and better the quality of their diagnosis and treatment delivery.

  • GE Healthcare continues expanding its healthcare technology portfolio through AI-enabled imaging systems, digital diagnostics, and strategic business expansion initiatives. The company generated approximately USD 19.6 billion in annual revenue while advancing regulatory-cleared imaging and monitoring technologies across more than 160 countries, positively supporting the global transition toward connected, data-driven, and precision-focused healthcare delivery systems.

The shift to value-based healthcare and the increasing interest in preventive health monitoring alongside the introduction of digital solutions is changing the situation with the usage of medical devices in the world. The industry is also on a promising path, but it is not without its challenges, including the fact that the strong approval procedures are expensive to comply with, prices are under pressure, and the supply chain is easily disturbed.

Nevertheless, the increased adoption of artificial intelligence (AI), Internet of Things (IoT), robotics, and telemedicine solutions is transforming the market to smarter, more connected, and patient-centric care delivery. In general, the medical devices market in the world is anticipated to experience long-term growth due to the innovation, the growing global medical needs and the ongoing transformation into digital, personalized, and affordable medical services.

  • Stryker continues accelerating medical device innovation through advanced robotic-assisted surgery systems, orthopedic technologies, and minimally invasive solutions. The company reported more than USD 20 billion in annual revenue while expanding regulatory-approved surgical and patient monitoring technologies, strengthening adoption of precision healthcare solutions and improving procedural efficiency, patient outcomes, and digital integration across healthcare facilities globally.

Medical Devices Market Drivers

Growing Geriatric Population and Chronic Disease Burden

The global increase in the geriatric population is a significant driver of the medical devices market. As people get aged, they are more susceptible to chronic and age-related health conditions such as cardiovascular diseases, diabetes, cancer, arthritis and stroke.
 
These conditions require continuous monitoring with timely diagnosis and effective management where all of which create increasing demand for advanced medical devices which include diagnostic tools, monitoring systems, surgical instruments and rehabilitation equipment.
 

  • According to IHME, non-communicable diseases contribute to nearly 43 million deaths annually worldwide, including more than 19 million cardiovascular-related deaths. The increasing elderly population and chronic disease prevalence are significantly driving demand for diagnostic imaging systems, patient monitoring technologies, surgical devices, and rehabilitation equipment across healthcare facilities globally.

Technological Advancements and Integration of Ai in Devices

Rapid technological advancements are transforming the medical devices market by increasing the precision, efficiency and effectiveness of healthcare delivery. Innovations in imaging, robotics, wearable sensors, and minimally invasive surgical tools are enabling more accurate diagnostics and improved patient outcomes. These developments reduce procedural risks, shorten recovery times, and streamline workflows which make the healthcare systems more efficient and reliable.
 
As a result, healthcare providers are increasingly adopting advanced devices which drive the growth of the overall market. Overall, the convergence of technological innovations and AI integration is a significant growth driver for the medical devices industry. Manufacturers are investing in research and development to introduce intelligent, connected and automated devices that meets the evolving clinical needs. This trend is creating opportunities for next-generation medical devices that support precision medicine, personalized care and data-driven healthcare solutions thereby expanding the market globally.
 

  • According to PubMed, AI-assisted diagnostic technologies have demonstrated accuracy levels exceeding 90% in several radiology and disease detection applications. Growing adoption of AI-enabled imaging, robotic-assisted surgery, wearable monitoring devices, and connected healthcare platforms is significantly improving diagnostic efficiency, clinical precision, workflow automation, and personalized patient care across the medical devices industry.

Rising Adoption of Ophthalmic Viscoelastic Devices in Cataract and Refractive Surgeries

Ophthalmic viscoelastic devices (OVDs) play an important role in modern eye surgeries, particularly cataract and refractive procedures. These viscoelastic solutions help maintain intraocular space to protect delicate ocular tissues and facilitate precise manipulation during surgery. As cataract and refractive surgeries continue to rise globally due to aging populations and increasing vision-related health awareness, the demand for OVDs has grown significantly which makes them an essential component of ophthalmic surgical procedures.
 
Overall, the increasing prevalence of cataract and refractive surgeries are combined with the critical role of viscoelastic solutions in improving surgical precision and safety is a strong growth driver for the ophthalmic medical devices market. Continuous product innovation, including next-generation biocompatible formulations which is expected to further accelerate adoption and expand opportunities in this niche but rapidly growing segment.
 

  • According to World Bank Health Data, global life expectancy has surpassed 73 years, contributing to a rapidly growing elderly population vulnerable to cataracts and vision disorders. Rising cataract surgical volumes worldwide are significantly increasing demand for ophthalmic viscoelastic devices, supporting improved intraocular protection, surgical precision, and recovery outcomes in ophthalmic and refractive procedures.

Market Segment Insights

By Application: Diagnostic Devices (Largest) vs. Therapeutic Devices (Fastest-Growing)

The application segment is critical, revealing distinct dynamics among its various categories. Diagnostic devices hold the largest share of the medical devices market at 56%, serving as essential tools for early disease detection and patient assessment. They are preferred not only for their efficacy but also for their increasing integration into personalized medicine. Conversely, therapeutic devices are emerging rapidly, reflecting a growing trend towards patient-centric care approaches and advanced treatment modalities.

GE Healthcare continues expanding AI-enabled imaging, ultrasound, and diagnostic monitoring technologies across global healthcare systems. With approximately USD 19.6 billion in annual revenue and operations in more than 160 countries, the company’s advanced diagnostic ecosystem supports rising adoption of early disease detection solutions and precision diagnostics across hospitals and specialty healthcare facilities.

By End Use: Hospitals (Largest) vs. Home Care (Fastest-Growing)

In the market, hospitals are currently the largest end-use segment, accounting for a substantial 62% share due to the high demand for advanced medical technologies and the extensive procedures performed in these facilities. Clinics also contribute significantly, but their share is steadily declining as more patients prefer outpatient treatments. Home care is gaining momentum, showing a shift towards personalized healthcare and remote monitoring, which has been further accelerated by the pandemic's emphasis on reducing hospital visits.

Stryker continues strengthening hospital-based healthcare infrastructure through robotic surgery platforms, orthopedic systems, and advanced patient care technologies. The company reported annual revenue exceeding USD 20 billion, reflecting strong global demand for hospital-centered surgical procedures, advanced treatment systems, and integrated healthcare technologies supporting complex medical interventions and inpatient care delivery.

By Device Type: Electromechanical Devices (Largest) vs. Implantable Devices (Fastest-Growing)

Electromechanical devices hold the largest share of the medical devices market at 48% among the various device types, reflecting their integral role in diagnostic and therapeutic applications. Surgical Instruments and In Vitro Diagnostic Devices follow closely, serving specialized medical procedures and laboratory environments. Wearable Devices are gaining traction, but they still share a smaller portion of the market compared to the established electromechanical and implantable categories.

Becton Dickinson and Company continues supporting healthcare providers through advanced infusion systems, diagnostic platforms, and medication delivery technologies. The company generates nearly USD 20 billion in annual revenue while processing billions of medication management interactions annually, positively supporting growing adoption of electromechanical devices in diagnostics, monitoring, and therapeutic healthcare applications worldwide.

By Technology: Digital Technology (Largest) vs. Telemedicine (Fastest-Growing)

The medical devices market is increasingly being shaped by various technological advancements, with digital technology holding the largest share at 52% among the different sub-segments. Digital Technology, which includes software-driven devices, remote monitoring, and data analytics tools, plays a crucial role in improving patient outcomes and operational efficiencies within healthcare settings. Telemedicine, while currently a smaller segment, is rapidly expanding its presence as healthcare providers embrace virtual consultations and remote patient management solutions.

Boston Scientific Corporation continues expanding digital healthcare integration through connected cardiovascular devices, remote patient monitoring systems, and minimally invasive technologies. The company invested more than USD 1.4 billion in annual R&D activities, supporting increasing adoption of software-driven healthcare solutions, real-time patient analytics, and digital treatment platforms across modern healthcare systems globally.

By Regulatory Classification: Class II Devices (Largest) vs. Class III Devices (Fastest-Growing)

The market showcases a distinct distribution across various regulatory classifications, with Class II devices holding the largest share of the medical devices market at 50%. These devices, which include essential items like infusion pumps and surgical lasers, account for a significant portion of the overall market due to their moderate-risk classification. In contrast, Class III devices, which necessitate more rigorous regulatory scrutiny, represent the fastest-growing segment, with a 30% share. This includes high-risk devices such as implantable pacemakers and coronary stents, reflecting the increasing focus on advanced medical technology and patient care.

Abbott continues strengthening its Class II medical device portfolio through diagnostic systems, diabetes monitoring platforms, and cardiovascular technologies. Abbott invests nearly USD 2.8 billion annually in research and development, while its FreeStyle Libre platform serves more than 6 million users globally, reflecting strong demand for moderate-risk, technologically advanced, and patient-centric medical devices.

Get more detailed insights about Medical Devices Market

Regional Insights

North America: Fastest growing healthcare system

North America leads in the Medical Devices Market Size, accounting for over 40% of the global revenue in 2024. The United States leads with 32% share, driven by advanced healthcare infrastructure and high adoption of innovative technologies, while Canada holds 8% supported by strong public healthcare investments.

  • According to CDC Data & Statistics (USA), the United States performs millions of diagnostic imaging and surgical procedures annually, significantly increasing demand for advanced monitoring, imaging, and minimally invasive medical technologies.

The United States holds the leadership position in the region market because of the presence of the major global vendors like Medtronic, Abbott, and Boston Scientific, as well as the developed ecosystem of innovation and clinical research. The market is growing at a high rate due to new investments in R&D and the speedy adoption of digital health technologies, including AI-based diagnostic tools, robotic-assisted surgery, and connected medical devices.

  • GE Healthcare generated approximately USD 19.6 billion in annual revenue while expanding AI-enabled imaging and digital healthcare technologies throughout North America. The company’s strong regional presence and continuous investments in connected diagnostics, patient monitoring systems, and precision healthcare innovation are positively supporting regional medical device adoption and healthcare modernization initiatives.

The increasing number of chronic illnesses such as cardiovascular diseases, diabetes and cancer is still generating the need of sophisticated diagnostic and treatment devices. Also, a growing trend toward home healthcare, distance monitoring and wearable medical equipment is transforming the way patients are served. Canada also makes some contribution, as there are favorable government policies regarding medical technology innovation and digitization of healthcare.

The U.S. Food and Drug Administration (FDA) regulatory control guarantees the quality, safety, and reliability of products, which results in a high level of consumer confidence. All in all, the technological leadership, patient awareness, and positive reimbursement structures in the region remain the key factors to its further dominance in the world medical devices market.

Medical Devices Market Regional Insights

Europe: Emerging Medical Devices

Europe Medical Devices Market size was valued at USD 192569.70 million in 2024, making it the second-largest regional market with a 30% share. The aging population, chronic diseases, and high demand of early disease detection and minimal invasive curative measures contribute to the growth of the region.

  • According to EMA (European Medicines Agency), Europe maintains one of the world’s most advanced healthcare regulatory systems, supporting safe adoption of innovative medical technologies and digital healthcare solutions.

Germany, United Kingdom and France are the significant contributors, which are backed with strong healthcare facilities and extensive government spending on national health.

  • Germany dominates with 9% due to strong medical technology manufacturing, while the United Kingdom holds 7% driven by increasing digital health adoption.

The EU Medical Device Regulation (MDR) has increased the level of transparency and patient safety in the market, though it has amplified the compliance costs on manufacturers. European companies lead in innovation of imaging systems, orthopedic implants and heart devices.

In addition, the trend of digital transformation in all healthcare systems is promoting the use of artificial intelligence-based diagnostic technologies, wearable health gadgets, and e-health applications. Sustainability and environmentally friendly manufacture processes are also on the agenda of the region, which is in line with the Green Deal policies of the EU.

Asia-Pacific: Development of healthcare system

Asia-Pacific region is also the fastest-growing market with the medical devices due to the growth of healthcare infrastructures, urbanization and growing healthcare awareness. Some of the top contributors include China, Japan, India and South Korea, with the benefits of increased disposable incomes and government policies to streamline healthcare systems. The high number of patients and the increasing incidence of chronic illnesses such as diabetes and cardiovascular diseases in the region are increasing the demand of the inexpensive diagnostic and therapeutic equipment.

  • China leads with 9% with market value at USD 57,771 Million supported by rapid healthcare expansion, while India accounts for 5% driven by rising healthcare investments and patient population growth.

China and Japan are international manufacturing and innovation centers, and their domestic production is high, and they have substantial investment in AI-based healthcare technologies. In the meantime, the emerging medical device manufacturing ecosystem in India with the assistance of the Make in India program and healthcare policy reform is becoming a source of foreign investment. There is an upsurge in the adoption of portable and home-care medical devices because of affordability and enhanced accessibility.

Moreover, the emergence of online healthcare startups and telemedicine portals is improving the provision of healthcare in the rural and underserved regions. Medical tourism also helps in growing the market in the region, especially in Thailand, Singapore and India. The Asia-Pacific market is likely to be a major source of medical device innovation and volume production on the planet in the next few years as regulatory frameworks continue to mature and the spending on healthcare increases.

Rest of the World: Emerging good medical devices

Rest of the World (RoW) segment - Latin America, Middle East and Africa - are emerging as a good area to grow medical devices. The growth of the market is influenced by the advancement of the healthcare infrastructure, the increase in the level of awareness about the disease and the growth of investment in the modernization of the hospitals. The main markets include Brazil, Mexico, Saudi Arabia, the UAE, and South Africa because of the current healthcare reforms and governmental promotion of the use of medical technologies.

The growing rate of infectious diseases, chronic diseases, and surgery is generating high demand of diagnostic, respiratory, and general surgery equipment. Nevertheless, regulatory systems, lack of uniform reimbursement systems and reliance on imported devices hinder growth in some regions. These barriers notwithstanding, multinational medical device firms are increasing their regional presence by partnering, manufacturing locally and training.

Middle East is especially making aggressive investments in new hospital facilities and electronic health care, Africa and Latin America are enjoying the fruits of international assistance and government-business initiatives in healthcare. The development of medical tourism and the rise in the involvement of the private sector is likely to make the RoW market one of the most important growth horizons of the world medical devices industry in the coming decade.

Medical Devices Market Regional Image

Key Players and Competitive Insights

Many global, regional, and local vendors characterize the Medical Devices Market. The market is highly competitive, with all the players competing to gain market share. Intense competition, rapid advances in technology, frequent changes in government policies, and environmental regulations are key factors that confront market growth. The vendors compete based on cost, product quality, reliability, and government regulations.
 
Vendors must provide cost-efficient, high-quality products to survive and succeed in an intensely competitive market. The major players in the market Include Johnson & Johnson, GE Healthcare, Stryker, Beckton Dickinson and Company, Boston Scientific Corporation, Abbott strategic market developments and decisions to improve operational effectiveness.

Key Companies in the Medical Devices Market include

Industry Developments

October 2025: Johnson & Johnson announced the Company’s intent to separate its Orthopaedics business to enhance the strategic and operational focus of each company and drive value for stakeholders. The intended separation would further strengthen the focus of Johnson & Johnson as an innovation powerhouse, serving areas of high unmet needs across Innovative Medicine and MedTech, accelerating the ongoing shift of the Company’s MedTech portfolio toward higher-growth and higher-margin markets.

July 2025: GE HealthCare has topped a U.S. Food and Drug Administration (FDA) list of AI-enabled medical device authorizations for the fourth year in a row with 100 listed authorizations to date in the U.S. This milestone reflects GE HealthCare’s continued research and development (R&D) investment and focus on developing AI solutions to advance precision care by enhancing medical devices across the care journey.

March 2025: Siemens Healthineers and Philips signed a strategic partnership to jointly develop and market advanced imaging technologies. This collaboration aims to combine Siemens Healthineers' expertise in imaging technology with Philips' strengths in data analytics and connected care solutions, creating more comprehensive healthcare solutions for hospitals and clinics.

Future Outlook

Medical Devices Market Future Outlook

The Medical Devices Industry size is projected to reach USD 1,377,540 Million by 2035, growing at a CAGR of 7.21%.

New opportunities lie in:

  • Expansion Of Home Healthcare and Remote Patient Monitoring
  • R&D Advancements in Next-Generation Biocompatible Viscoelastic Solutions.

By 2035, the Medical Devices Industry is expected to achieve substantial growth and innovation.

Market Segmentation

Medical Devices Market by End User Outlook

  • Hospitals & Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings
  • Others

Medical Devices Market by Application Outlook

  • Cardiovascular Diseases
  • Diagnostic Imaging
  • Orthopedics
  • Oncology
  • General Surgery
  • Respiratory
  • ENT
  • Neurology
  • Nephrology & Urology
  • Others

Medical Devices Market Protection by Device Type Outlook

  • Drug Delivery Systems
  • Diagnostic Devices
  • Invasive Devices
  • Respiratory Therapeutic Devices
  • Electronic Medical Devices
  • Others

Report Scope

Market Size 2024

6,41,899(USD Million)

Market Size 2025

6,88,180 (USD Million)

Market Size 2035

13,77,540 (USD Million)

Compound Annual Growth Rate (CAGR)

7.21% (2025 - 2035)

Report Coverage

Revenue Forecast, Competitive Landscape, Growth Factors, and Trends

Base Year

2024

Market Forecast Period

2025 - 2035

Historical Data

2019 - 2023

Market Forecast Units

USD Million

Key Companies Profiled

Johnson & Johnson, GE Healthcare, Stryker, Beckton Dickinson and Company, Boston Scientific Corporation, Abbott

Segments Covered

By Device Type, By Application, By End User

Key Market Opportunities

Expansion Of Home Healthcare and Remote Patient Monitoring.

R&D Advancements in Next-Generation Biocompatible Viscoelastic Solutions.

Key Market Dynamics

Growing Geriatric Population and Chronic Disease Burden.

Technological Advancements and Integration of Ai in Devices.

Rising Adoption of Ophthalmic Viscoelastic Devices In Cataract and Refractive Surgeries.

Region Covered

North America, Europe, APAC, Rest of the world.

 

FAQs

What is the current valuation of the medical devices market as of 2024?

The medical devices market was valued at 590.0 USD Billion in 2024.

What is the projected market valuation for the medical devices market in 2035?

The market is projected to reach 850.0 USD Billion by 2035.

What is the expected CAGR for the market during the forecast period 2025 - 2035?

The expected CAGR for the market during 2025 - 2035 is 3.37%.

Which companies are considered key players in the medical devices market?

Key players include Medtronic, Abbott Laboratories, Boston Scientific, Johnson & Johnson, Siemens Healthineers, Philips, Stryker Corporation, Baxter International, and GE Healthcare.

What are the major segments of the medical devices market by application?

Major segments by application include Diagnostic Devices, Therapeutic Devices, Monitoring Devices, Surgical Devices, and Rehabilitation Devices.

How much was the market size for surgical devices in 2024?

The market size for surgical devices was 150.0 USD Billion in 2024.

What is the projected market size for monitoring devices by 2035?

The market size for monitoring devices is projected to reach 140.0 USD Billion by 2035.

What are the end-use segments in the medical devices market?

End-use segments include Hospitals, Clinics, Home Care, Research Laboratories, and Ambulatory Surgical Centers.

What is the market size for implantable devices in 2024?

The market size for implantable devices was 150.0 USD Billion in 2024.

What technological advancements are influencing the medical devices market?

Technological advancements include Digital Technology, Biotechnology, Nanotechnology, Robotics, and Telemedicine.
Author
Author
Author Profile
Satyendra Maurya LinkedIn
Research Analyst
An accomplished research analyst with high proficiency in market forecasting, data visualization, competitive benchmarking, and others. He holds a pronounced track record in research and consulting projects for sectors such as life sciences, medical devices, and healthcare IT. His capabilities in qualitative and quantitative analysis have resulted in positive client outcomes. Working on niche market trends, opportunities, sales, and forecasted value is part of his skill set.
Co-Author
Co-Author Profile
Rahul Gotadki LinkedIn
Research Manager
He holds an experience of about 9+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc.
Leave a Comment

Research Approach

 

Secondary Research

The secondary research process involved comprehensive analysis of regulatory databases, international standards bodies, peer-reviewed clinical journals, medical device industry associations, and authoritative health organizations. Key sources included the US Food & Drug Administration (FDA) 510(k) and PMA databases, European Medicines Agency (EMA) and Notified Bodies under Medical Device Regulation (MDR 2017/745) and In Vitro Diagnostic Regulation (IVDR 2017/746), International Organization for Standardization (ISO) 13485 and ISO 14971 standards, International Electrotechnical Commission (IEC) 60601 series, Advanced Medical Technology Association (AdvaMed), MedTech Europe, Health Canada Medical Devices Bureau, Pharmaceuticals and Medical Devices Agency (PMDA Japan), National Medical Products Administration (NMPA China), Therapeutic Goods Administration (TGA Australia), National Institutes of Health (NIH), National Center for Biotechnology Information (NCBI/PubMed), Centers for Disease Control and Prevention (CDC) National Health Statistics, World Health Organization (WHO) Medical Device Policy and Global Health Observatory, OECD Health Statistics, World Bank Health, Nutrition and Population Statistics, EU Eurostat Healthcare Data, and national health ministry reports from key markets including China NHC, India CDSCO, and Brazil ANVISA.

Medical device approval data, regulatory pathway analysis, procedure volumes, hospital equipment procurement statistics, reimbursement codes, clinical safety studies, and market landscaping for diagnostic imaging systems, surgical robotics, patient monitoring devices, cardiovascular implants, and orthopedic prosthetics were gathered from these sources.

 

Primary Research

Qualitative and quantitative insights were obtained by interviewing supply-side and demand-side stakeholders during the primary research process. CEOs, VPs of Research & Development, regulatory affairs chiefs, quality assurance directors, and commercial directors from medical device manufacturers, OEMs, and contract manufacturers comprised supply-side sources. Chief medical officers, department heads in cardiology and radiology, biomedical engineers, procurement administrators from hospital systems, group purchasing organizations (GPOs), clinical laboratories, and ambulatory surgery centers comprised demand-side sources. Primary research verified market segmentation across device categories, confirmed product pipeline timelines for Class II and Class III devices, and collected insights on technology adoption patterns, sterilization standards compliance, pricing strategies, reimbursement dynamics, and supply chain disruptions.

Primary Respondent Breakdown:

By Designation: C-level Primaries (32%), Director Level (35%), Others (33%)

By Region: North America (38%), Europe (30%), Asia-Pacific (25%), Rest of World (7%)

 

Market Size Estimation

Revenue mapping and procedural volume analysis were implemented to determine global market valuation. The methodology comprised the following:

Identification of 55+ key manufacturers in North America, Europe, Asia-Pacific, and Latin America that specialize in diagnostic imaging (MRI, CT, ultrasound), surgical devices (robotic systems, electrosurgical), patient monitoring (ICU, wearable), and implantable technologies (stents, pacemakers, orthopedic implants).

Active implantable devices are included in the product classification of Class I, Class II, and Class III medical device categories.

Examination of annual revenues pertaining to medical device portfolios and their subdivision by application areas (ophthalmology, neurology, orthopedics, and cardiology) as reported and modeled

Manufacturers that account for 75-80% of the global market share in 2024 are included in the coverage.

Segment-specific valuations across hospitals, clinics, and home healthcare contexts are derived through extrapolation using bottom-up (procedure volume × ASP by country/region) and top-down (manufacturer revenue validation, GPO contract analysis) approach.

Download Free Sample

Kindly complete the form below to receive a free sample of this Report